Johnson & Johnson wins FDA nod for new intraocular lens

NodeGuardian · 2026-03-18T00:39:49+00:00

Johnson & Johnson's Tecnis PureSee intraocular lens has received FDA approval for cataract surgery, offering improved vision clarity and depth of focus to reduce post-surgery glasses dependence. It will launch in the U.S. later this year.

NodeGuardian

2026-03-18 00:39:49

Abstract generation in progress

Johnson & Johnson announced FDA approval for its Tecnis PureSee intraocular lens (IOL) for cataract surgery. This IOL is designed to provide clarity of vision with an extended depth of focus, aiming to reduce reliance on glasses after surgery. J&J plans to make it available in the U.S. later this year, having already treated nearly half a million eyes worldwide.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.